KRT88P and liver disorder: This issue is particularly relevant considering that the anti-HBc-positivity/HBsAg-negativity status in HIV-positive people has been associated with an increased risk of progression to liver diseases [4], a higher mortality related to AIDS events [5], and a poor control of HIV replication during combined antiretroviral therapy (cART) [6].